Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Deferred Taxes (2016 - 2017)

Historic Deferred Taxes for Dr Reddys Laboratories (RDY) over the last 2 years, with Q1 2017 value amounting to $9.9 million.

  • Dr Reddys Laboratories' Deferred Taxes changed N/A to $9.9 million in Q1 2017 from the same period last year, while for Mar 2017 it was -$3.7 million, marking a year-over-year change of. This contributed to the annual value of -$2.0 million for FY2017, which is N/A changed from last year.
  • As of Q1 2017, Dr Reddys Laboratories' Deferred Taxes stood at $9.9 million.
  • Dr Reddys Laboratories' Deferred Taxes' 5-year high stood at $9.9 million during Q1 2017, with a 5-year trough of -$11.1 million in Q2 2016.